LifeStance Health Group, Inc. LFST NASDAQ

LifeStance Health Group, Inc. (LFST) generated $146.15M in operating cash flow for fiscal year 2025. After capital expenditures of $36.13M, free cash flow was $110.03M.

Free cash flow margin was 7.7% of revenue. Cash conversion ratio was 15.12x, indicating earnings are backed by cash.

Criteria supported by this page:

• HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
• MOAT (49/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (30/100) — Cash conversion ratio was 15.12x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 59/100 with 2/7 criteria passed.